Cetera Advisor Networks LLC Aurinia Pharmaceuticals Inc. Transaction History

Cetera Advisor Networks LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.77 - $12.27 $5,773 - $9,116	-743 Reduced 6.74%	10,279 $79,000
Q3 2022 Nov 10, 2022	BUY	$6.66 - $12.39 $73,406 - $136,562	11,022 New	11,022 $83,000
Q1 2022 May 12, 2022	SELL	$10.05 - $22.48 $96,590 - $216,055	-9,611 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $170,883 - $317,931	9,611 New	9,611 $220,000
Q3 2020 Nov 13, 2020	SELL	$13.19 - $16.66 $12,134 - $15,327	-920 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $12,990 - $16,863	920 New	920 $15,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.